Antifibrotics with Cross-Indication Potential: Challenges and Progress Towards a Universal Fibrosis-Modifying Therapy
: Organ fibrosis is a chronic, progressive condition that frequently results in organ dysfunction and failure. Despite its high morbidity and mortality, substantial therapeutic gaps persist for fibrosis across all organ systems. The compartmentalization of fibrosis research by organ system has impeded the development o...